Globe Newswire

CLEVELAND, May 14, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, placebo-controlled trial of individuals experiencing moderate-to-severe postoperative pain following knee replacement and treatment with the SPRINT PNS System. The study, published in the journal Neuromodulation, highlights the results from the prospective trial evaluating the impact of 60-day peripheral nerve stimulation (PNS) used for... (continue reading...)

BRISBANE, Australia, May 15, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX), a leading battery materials and technology company, and PowerCo SE (“PowerCo”), a Volkswagen Group-owned battery cell company, have announced the signing of a non-exclusive Testing and Development Agreement (“TDA”). The work to be conducted under the TDA will include NOVONIX developing, testing, and analyzing synthetic graphite anode materials tailored to meet... (continue reading...)

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Sulliden Mining Capital Inc. (TSX: SMC) (“Sulliden” or the “Company”) is pleased to announce that Scott Moore has been appointed as the president and chief executive officer and a director of the Company, effective immediately.

Mr. Moore is a business executive with over 30 years of experience in the resource and durable goods sectors. He is the CEO of O2Gold Inc. and the former CEO of Euro Sun Mining Inc.,... (continue reading...)

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the “Class Period”), of the important July 1, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Globe Life common stock during the Class Period you may be entitled to compensation without payment of any... (continue reading...)

EINDHOVEN, the Netherlands, May 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will host a webcast to discuss its Q1 2024 business highlights.

The webcast will be held on May 23, 2024, at 2:30PM CET / 08:30AM ET. It will be hosted by CEO Dave Marver... (continue reading...)